Objective: Test the efficacy of the selective orexin 1 receptor (OX1R) antagonist (SO1RA) nivasorexant in an animal model of binge-eating disorder (BED) and study its dose-response relationship considering free brain concentrations and calculated OX1R occupancy. Compare nivasorexant's profile to that of other, structurally diverse SO1RAs. Gain understanding of potential changes in orexin-A (OXA) neuropeptide and deltaFosB (ΔFosB) protein expression possibly underlying the development of the binge-eating phenotype in the rat model used.

Method: Binge-like eating of highly palatable food (HPF) in rats was induced through priming by intermittent, repeated periods of dieting and access to HPF, followed by an additional challenge with acute stress. Effects of nivasorexant were compared to the SO1RAs ACT-335827 and IDOR-1104-2408. OXA expression in neurons and neuronal fibers as well as ΔFosB and OXA-ΔFosB co-expression was studied in relevant brain regions using immuno- or immunofluorescent histochemistry.

Results: All SO1RAs dose-dependently reduced binge-like eating with effect sizes comparable to the positive control topiramate, at unbound drug concentrations selectively blocking brain OX1Rs. Nivasorexant's efficacy was maintained upon chronic dosing and under conditions involving more frequent stress exposure. Priming for binge-like eating or nivasorexant treatment resulted in only minor changes in OXA or ΔFosB expression in few brain areas.

Discussion: Selective OX1R blockade reduced binge-like eating in rats. Neither ΔFosB nor OXA expression proved to be a useful classifier for their binge-eating phenotype. The current results formed the basis for a clinical phase II trial in BED, in which nivasorexant was unfortunately not efficacious compared with placebo.

Public Significance: Nivasorexant is a new investigational drug for the treatment of binge-eating disorder (BED). It underwent clinical testing in a phase II proof of concept trial in humans but was not efficacious compared with placebo. The current manuscript investigated the drug's efficacy in reducing binge-like eating behavior of a highly palatable sweet and fat diet in a rat model of BED, which initially laid the foundation for the clinical trial.

Download full-text PDF

Source
http://dx.doi.org/10.1002/eat.24181DOI Listing

Publication Analysis

Top Keywords

binge-like eating
20
binge-eating disorder
12
efficacy selective
8
selective orexin
8
orexin receptor
8
nivasorexant animal
8
animal model
8
model binge-eating
8
disorder bed
8
binge-eating phenotype
8

Similar Publications

Binge eating (BE) is a highly pervasive maladaptive coping strategy in response to severe early life stress such as emotional and social neglect. BE is described as repeated episodes of uncontrolled eating and is tightly linked with comorbid mental health concerns. Despite social stressors occurring at a young age, the onset of BE typically does not occur until adulthood providing an interval for potential therapeutic intervention.

View Article and Find Full Text PDF

Differential exposure to palatable food and its effects on binge-like eating behavior in adolescent rats.

Front Psychol

November 2024

Facultad de Estudios Superiores Iztacala, UNAM. Laboratorio de Neurobiología de la Alimentación, Tlalnepantla, Estado de México, Mexico.

Article Synopsis
  • The study examines how different access protocols to palatable food (PF) influence binge-like eating behaviors in adolescent male Wistar rats, which may be relevant for understanding human obesity.
  • Three groups of rats were given varying access to PF—continuous, intermittent, and weekend access—over a period of six weeks, followed by a withdrawal period.
  • Results showed that restricted access led to increased binge-like eating, with the intermittent access group exhibiting the highest levels of binge eating, highlighting how food availability affects consumption patterns during adolescence.
View Article and Find Full Text PDF
Article Synopsis
  • - Psychological stress influences eating behavior by decreasing regulated food intake while increasing the consumption of pleasurable foods.
  • - In experiments with rats, acute stress led to less consumption of regular food but a higher intake of a dessert food, while chronic stress resulted in reduced overall calorie intake, including binge eating episodes.
  • - Binge eating high-fat diets under chronic stress not only caused metabolic issues but also shifted stress coping strategies, potentially raising the risk for stress-related disorders like depression.
View Article and Find Full Text PDF

Childhood obesity is a multifactorial disease affecting more than 160 million adolescents worldwide. Adolescent exposure to obesogenic environments, characterized by access to high-fat diets and stress, precipitates maladaptive eating habits in adulthood such as binge eating. Evidence suggests a strong association between Western-like high-saturated-fat (WD) food consumption and dysregulated hormone fluctuations.

View Article and Find Full Text PDF

Endogenous opioids facilitate stress-induced binge eating via an insular cortex-claustrum pathway.

bioRxiv

June 2024

Center for the Neurobiology of Addiction, Pain and Emotion;Departments of Anesthesiology, Pharmacology, and Bioengineering, University of Washington, Seattle, WA, USA.

Stress has been shown to promote the development and persistence of binge eating behaviors. However, the neural circuit mechanisms for stress-induced binge-eating behaviors are largely unreported. The endogenous dynorphin (dyn)/kappa opioid receptor (KOR) opioid neuropeptide system has been well established to be a crucial mediator of the anhedonic component of stress.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!